Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Doxycycline hyclate for MMP-Driven BBB Studies
2026-08-21
Doxycycline hyclate is a practical matrix metalloproteinases inhibitor for connecting MMP-2/MMP-9 activity with blood–brain barrier integrity, neuronal apoptosis, and behavioral outcomes. This guide translates a mouse arsenic-exposure study into executable assay workflows while clarifying formulation, controls, troubleshooting, and cross-domain research opportunities.
-
2'3'-cGAMP: From mtDNA Leakage to STING Translation
2026-08-20
Chronic NAD depletion can connect metabolic stress to mitochondrial DNA leakage and cGAS-STING signaling. This thought-leadership guide explains how 2'3'-cGAMP (sodium salt) can function as a proximal STING pathway control while helping translational researchers distinguish pathway activation from upstream mechanism.
-
Beyond Glycemia: Trelagliptin and Bone Biology
2026-08-20
Trelagliptin succinate, also known as SYR-472 succinate, offers translational researchers a way to connect selective DPP-4 enzyme inhibition with glucose regulation, AMPK signaling, and osteoblastic differentiation. This thought-leadership analysis examines the evidence, experimental design priorities, competitive positioning, and limits of extending a diabetes research tool into bone biology.
-
Exendin-4: Mechanism-First GLP-1 Assay Design
2026-08-19
Exendin-4, also known as Exenatide, is more than a GLP-1 receptor agonist: it is a layered experimental probe for cAMP signaling, beta cell function, and metabolic phenotypes. This guide connects assay endpoint selection with recent advances in stable peptide expression and practical reagent control.
-
Brefeldin A: Reliable ER Stress Assays
2026-08-19
Brefeldin A (BFA), SKU B1400, offers a defined approach for probing ER-to-Golgi trafficking, ER stress, and cancer-cell viability responses. This scenario-based guide helps researchers select concentrations, control solvent and storage variables, interpret cytotoxicity data, and distinguish mechanistic effects from assay artifacts.
-
Bovine Insulin for Reproducible Cell Assays
2026-08-18
Bovine insulin provides a defined way to support proliferation, metabolism, and survival measurements without treating a culture supplement as a therapeutic variable. This workflow connects insulin-controlled cell culture with a glioblastoma senescence model, helping researchers separate metabolic effects from delayed drug-induced cell death.
-
Silymarin as a Translational Mechanistic Probe
2026-08-18
Silymarin is more than a conventional milk thistle extract: it is a chemically heterogeneous flavonolignan reference material whose value depends on rigorous identity, solvent, assay, and interpretation controls. This thought-leadership guide connects its chemistry to oxidative stress, hepatocellular carcinoma, metabolic, and antiviral research while defining a practical path toward more reproducible translational studies.
-
Canagliflozin Workflows for Renal Research
2026-08-17
Canagliflozin enables controlled studies of SGLT2-dependent glucose transport, proximal-tubule injury, and mitochondrial remodeling. This workflow-focused guide connects concentration design, diabetic-animal studies, bioenergetics assays, and troubleshooting to help researchers separate glucose-lowering effects from kidney-cell adaptations.
-
Exendin-4: From cAMP Biology to Scalable Translation
2026-08-17
Exendin-4, also known as Exenatide, is more than a GLP-1 receptor agonist for routine insulin-secretion assays. Its cAMP-centered mechanism, metabolic research applications, and emerging yeast-expression strategies make it a valuable reference point for translational type 2 diabetes research, from beta cell function research to manufacturing accessibility.
-
Tolazoline in Reliable Cell Assay Workflows
2026-08-16
Tolazoline (SKU A8991) offers a documented way to interrogate α2-adrenergic signaling, airway neurotransmission, and β-cell potassium-channel biology without mistaking pharmacological effects for nonspecific cytotoxicity. This scenario-based guide covers assay design, concentration selection, solvent handling, interpretation, and practical product selection.
-
GSK-3 Control for Tunable Human Organoids
2026-08-15
CHIR 99021 trihydrochloride offers translational researchers a precise way to interrogate GSK-3-dependent stemness, lineage balance, insulin signaling, and metabolic phenotypes in organoid and disease-modeling workflows.
-
MK 0893: From GCGR Mechanism to Translation
2026-08-14
MK 0893 illustrates how allosteric glucagon receptor antagonism can connect receptor pharmacology, cellular cAMP assays, animal models, and translational decision-making in type 2 diabetes research.
-
Anagliptin (SK-0403) in Vascular Research
2026-08-14
Anagliptin (SK-0403) combines a well-defined DPP-4 inhibition mechanism with a practical probe for vascular smooth-muscle signaling. This workflow shows how to connect biochemical target engagement with rabbit aortic-ring assays that resolve Kv channel modulation and SERCA pump regulation.
-
PPARγ, Macrophage Polarization, and DSS-Induced IBD
2026-08-13
This study links PPARγ activation to macrophage M1/M2 polarization and reduced DSS-induced intestinal inflammation through coordinated changes in STAT-1 and STAT-6 signaling. Its combined cellular and mouse-model design provides a mechanistic framework for studying PPARγ-dependent inflammatory process modulation while highlighting important limits on translation beyond experimental IBD.
-
Rotigotine and Bladder Function in Parkinson’s Rats
2026-08-13
This rat study examined how rotigotine alters lower urinary tract function after 6-hydroxydopamine-induced dopaminergic injury. Its main innovation was to show that the effect depends strongly on administration route: acute intravenous dosing shortened the intercontraction interval, whereas subcutaneous dosing lengthened it and suppressed bladder overactivity.